Plasmodium Vivax Malaria: Clinical Trials

5 trials for Plasmodium Vivax Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Recruiting 2, Terminated 1

Follow Plasmodium Vivax Malaria: new trials by email Literature Review of Plasmodium Vivax Malaria trials Research Report on Plasmodium Vivax Malaria

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vivax Elimination With Tafenoquine (VET) Study
Tafenoquine - Malaria, Malaria, Vivax
Phase 4CompletedShoklo Malaria Research Unit12422025-02-192026-01-06
Southeast Asia Dose Optimization of Tafenoquine
Tafenoquine, Chloroquine, Artemether 20 mg-Lumefantrine 120 mg - Plasmodium Vivax Malaria
Phase 4RecruitingUniversity of Oxford8202024-07-222026-10-09
ACT vs CQ With Tafenoquine for P. Vivax Mono-infection
Dihydroartemisinin-piperaquine plus tafenoquine (450 mg adult dose), Chloroquine plus Tafenoquine (450 mg adult dose), Artemether-Lumefantrine plus Tafenoquine (450 mg adult dose) - Malaria, Malaria, Vivax
Phase 4RecruitingShoklo Malaria Research Unit6062023-06-262025-05-16
Antimalarial Drug Susceptibility and Molecular Characterization of Plasmodium Vivax Isolates in Vietnam
Chloroquine, Dihydroartemisinin/Piperaquine - Plasmodium Vivax Malaria
Phase 4CompletedOxford University Clinical Research Unit, Vietnam3302013-02-012016-09-30
Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)
Mefloquine- Artesunate, Artemether-Lumefantrine, Chloroquine - Plasmodium Vivax Malaria
Phase 4TerminatedCenters for Disease Control and Prevention162011-02-012012-04-13

Narrower conditions

Malaria, Vivax (5)  ·  Malaria (3)  ·  Recurrence (1)

Broader conditions

Infections (5)  ·  Mosquito-Borne Diseases (5)  ·  Parasitic Diseases (5)  ·  Protozoan Infections (5)  ·  Vector Borne Diseases (5)  ·  Malaria (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Chloroquine (4)  ·  tafenoquine (3)  ·  Artemether, Lumefantrine Drug Combination (2)  ·  artenimol (2)  ·  piperaquine (2)  ·  Artemether (1)  ·  Lumefantrine (1)  ·  Primaquine (1)  ·  lactitol (1)

Sponsors

Shoklo Malaria Research Unit (2)  ·  Centers for Disease Control and Prevention (1)  ·  Oxford University Clinical Research Unit, Vietnam (1)  ·  University of Oxford (1)

Countries

Thailand (3)  ·  Vietnam (2)  ·  Brazil (1)  ·  Cambodia (1)  ·  Indonesia (1)  ·  Laos (1)

Top investigators

Cindy Chu, MD, PhD (1)  ·  Francois Nosten, Prof (1)  ·  Meghna Desai, MPH PhD (1)

Results publications

PMID 22531245, PMID 23212366, PMID 29398388, PMID 30698522